The present invention relates to a new formulation comprising L-theanine.

The present invention relates to a new formulation comprising L-theanine.

An energy supplement composition, such as a small-volume “shot” drink, comprises ingredients formulated to enhance not only the energy of a consumer but also the focus and mood of the consumer. Therefore, the composition comprises at least one energy-enhancing ingredient (e.g., caffeine, methylliberine), at least one mood-enhancing ingredient (e.g., theanine), and at least one focus-enhancing ingredient (e.g., citicoline and/or alpha-GPC and uridine monophosphate). The composition may be free of “fillers,” such as taurine, choline bitartrate, and glucuronolactone. Related energy supplement drinks and other compositions are also disclosed.

An energy supplement composition, such as a small-volume “shot” drink, comprises ingredients formulated to enhance not only the energy of a consumer but also the focus and mood of the consumer. Therefore, the composition comprises at least one energy-enhancing ingredient (e.g., caffeine, methylliberine), at least one mood-enhancing ingredient (e.g., theanine), and at least one focus-enhancing ingredient (e.g., citicoline and/or alpha-GPC and uridine monophosphate). The composition may be free of “fillers,” such as taurine, choline bitartrate, and glucuronolactone. Related energy supplement drinks and other compositions are also disclosed.

Provided herein are formulations and methods helping individuals enhance cognitive function, facilitate memory processing, induce and maintain sleep, stabilize mood, reduce symptoms of stress and anxiety, facilitate energy production, improve mental and emotional health, or support long-term brain health.

Provided herein are formulations and methods helping individuals enhance cognitive function, facilitate memory processing, induce and maintain sleep, stabilize mood, reduce symptoms of stress and anxiety, facilitate energy production, improve mental and emotional health, or support long-term brain health.

The present invention applies in the field of compositions and supplements and multivitamins. The present invention discloses a multivitamin composition which provides an improvement in speech fluency and the performance anxiety control, when administered to patients in therapeutically effective amounts.

The present invention applies in the field of compositions and supplements and multivitamins. The present invention discloses a multivitamin composition which provides an improvement in speech fluency and the performance anxiety control, when administered to patients in therapeutically effective amounts.

In general, certain embodiments of the present disclosure provide compositions or mechanisms for oral administration of caffeine via a functional nutraceutical confectionary composition. According to various embodiments, a nutraceutical confectionary composition is provided with a ratio of caffeine to L-theanine ranging from about 1:1 to about 1:2. In some embodiments, the ratio of caffeine to L-theanine is about 2:3. In various embodiments, the nutraceutical confectionary composition may provide caffeine in a range from about 5 mg to about 100 mg per serving. L-theanine may be provided in a range from about 5 mg to about 200 mg per serving. In some embodiments, caffeine may comprise about 0.8% to 10% by weight of the composition; and L-theanine may comprise about 1.2% to 20% by weight of the composition. In certain embodiments, the nutraceutical confectionary composition may comprise a chewing gum.

In general, certain embodiments of the present disclosure provide compositions or mechanisms for oral administration of caffeine via a functional nutraceutical confectionary composition. According to various embodiments, a nutraceutical confectionary composition is provided with a ratio of caffeine to L-theanine ranging from about 1:1 to about 1:2. In some embodiments, the ratio of caffeine to L-theanine is about 2:3. In various embodiments, the nutraceutical confectionary composition may provide caffeine in a range from about 5 mg to about 100 mg per serving. L-theanine may be provided in a range from about 5 mg to about 200 mg per serving. In some embodiments, caffeine may comprise about 0.8% to 10% by weight of the composition; and L-theanine may comprise about 1.2% to 20% by weight of the composition. In certain embodiments, the nutraceutical confectionary composition may comprise a chewing gum.